The American Legion wants medical marijuana research for veterans
The American Legion is calling on Congress to reconsider its position on marijuana, asking lawmakers to remove the drug from Schedule 1 of the federal Controlled Substances Act and reclassify it as a drug with “potential medical value.”
In a resolution passed at the 98th National Convention of the American Legion on Sept. 1, the Legion’s Veterans Affairs and Rehabilitation Convention Committee unanimously recommended the delegates pass a resolution urging the DEA to “license privately-funded medical marijuana production operations in the United States to enable safe and efficient cannabis drug development research.”
Officials with the American Legion say there’s some evidence marijuana helps in the treatment of Traumatic Brain Injury and PTSD. Research conducted by the Legion’s Ad Hoc Committee on TBI/PTSD found that the conditions cost the economy $60 billion.
“The response of the membership has been very positive,” says William Detweiler, the chairman of the Legion’s Ad Hoc Committee on TBI/PTSD. “Our veterans deserve the best medical care that we can offer. We believe that funding additional medical research in this field will provide another ‘tool’ in the physician’s toolbox for treatment.”
In 2011, the Ad Hoc Committee was formed to look into the issues surrounding the treatment of veterans suffering from traumatic brain injuries and Post-Traumatic Stress. The goal was to determine what treatments are being employed by VA and DoD currently and what other treatments and protocols that may be available that are not being currently used or approved.
Schedule 1 of the federal Controlled Substances Act includes drugs like marijuana, heroin, and LSD while Schedule 2 includes oxycodone, morphine, and Ritalin.
Now that the national convention passed the resolution supporting medical marijuana research for veterans with certain conditions, the National Commander of the American Legion and the staff can urge Congress and the DEA to provide funds for research on medical cannabis.
Army Surgeon General Lt. Gen. Nadja West said marijuana is still an illegal drug and soldiers using it will face discipline, but she sees some benefit to using chemicals within pot to treat PTSD and TBI.
“Using marijuana has a lot of adverse health effects, it’s surprising that’s not brought out when they’re trying to legalize it. … It’s more dangerous that some of the carcinogens that are in tobacco,” West said during a media roundtable in Washington. “But if there’s some component of [marijuana] that can be useful to treat our service members, anyone who has post-traumatic stress disorder … I’m for that.”
The American Legion did not survey the 2.4 million veterans it represents to find their feelings on medical marijuana but has found their constituents to be generally receptive to the idea.
“Veterans are exhausted and feel like guinea pigs; they’re getting desperate,” said Dr. Sue Sisley, a researcher from Arizona who spoke at the Legion’s National Convention. “It’s a big breakthrough. While I can’t say definitively that medical marijuana works for PTSD – we are three years away from published data – we owe it to veterans to study this plant.”